Simplify Logo

Full-Time

Scientist/Senior Scientist

Translational Aging

Confirmed live in the last 24 hours

Calico Labs

Calico Labs

201-500 employees

Research and develop treatments for aging

Biotechnology

Compensation Overview

$127k - $172kAnnually

+ Cash Bonus

Entry, Junior, Mid, Senior

San Bruno, CA, USA

Category
Computational Biology
Genomics
Biology & Biotech
Requirements
  • PhD or MD-PhD with 0- 9 years experience
  • Excellent analytical skills and a creative and curious mind
  • Proven track record of high-quality laboratory research and publications
  • Strong working knowledge of genetics, cell biology, molecular genetics and physiology
  • Excellent computational skills
  • Effective speaker and writer
  • Strong technical skills at the bench
  • Excellent leadership skills and the ability to lead and collaborate with cross-functional teams and external partners.
  • Must be willing to work onsite five days per week
  • Must submit a cover letter with your application
Responsibilities
  • Identify and validate translational targets for aging
  • Rigorously evaluate the case that perturbing the target is likely to slow all or part of aging and extend human health span
  • Identify and evaluate potential disease indications
  • Evaluate the target from the perspective of safety, freedom to operate, competitive landscape, regulatory feasibility and draggability (using chemical, biologic or genetic interventions)
  • Master and follow the relevant biological field and incorporate new findings into your validation strategy
  • At the bench and leading cross-functional teams, design and execute target validation experiments that would justify a focused drug development effort
  • Analyze experimental data rigorously and critically, and modify your strategy as appropriate
  • Provide effective and inspirational leadership for cross-functional project teams
  • Provide project management required to ensure successful execution
  • Terminate projects and move on when appropriate
  • Contribute to Calico’s collaborative and innovative research environment
  • Collaborate with internal and external partners, including academic institutions and industry collaborators, to best advance the research science
  • Contribute to impactful publications and scientific presentations, both internally and externally

Calico Labs focuses on researching the biology of aging and creating treatments for diseases related to aging. The company conducts scientific research to understand how aging works and what causes age-related diseases. It collaborates with academic institutions and other biopharmaceutical companies to enhance its research efforts. Calico Labs uses advanced technologies and encourages teamwork among scientists from different fields to speed up the discovery of new medical treatments. The company earns money through partnerships, joint research projects, and grants, which help fund its work. The main goal of Calico Labs is to make important advancements in understanding aging and to develop effective therapies for age-related conditions.

Company Stage

Seed

Total Funding

$2M

Headquarters

South San Francisco, California

Founded

2013

Growth & Insights
Headcount

6 month growth

8%

1 year growth

8%

2 year growth

8%
Simplify Jobs

Simplify's Take

What believers are saying

  • The inclusion of fosigotifator in the FDA's START Pilot Program highlights Calico Labs' potential to develop groundbreaking treatments for rare diseases.
  • Extending the collaboration with the Broad Institute until 2029 ensures continued progress in understanding aging and developing therapies for age-related neurodegeneration.
  • The appointment of renowned experts like Michael Lenardo, M.D., as Chief Scientific Officer strengthens Calico Labs' leadership and scientific expertise.

What critics are saying

  • The highly specialized focus on aging and age-related diseases may limit the company's market opportunities compared to broader biopharmaceutical firms.
  • Dependence on strategic partnerships and collaborations could pose risks if these alliances face challenges or dissolve.

What makes Calico Labs unique

  • Calico Labs focuses exclusively on the biology of aging and age-related diseases, setting it apart from other biopharmaceutical companies with broader research scopes.
  • Their strategic partnerships with leading academic institutions and biopharmaceutical firms, such as the Broad Institute and AbbVie, enhance their research capabilities and accelerate innovation.
  • Calico Labs' emphasis on interdisciplinary collaboration and advanced technologies fosters a unique research environment that drives significant scientific discoveries.